Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jamie B. Howell"'
Autor:
Mirko Sikirica, Nicole Cobb, Bhaskar R. Nuthulaganti, Hope He, Janice L. Clarke, Vittorio Maio, Christine Weston, Christine W. Hartmann, Neil I. Goldfarb, Jamie B Howell, Albert G. Crawford
Publikováno v:
Disease Management. 7:61-75
This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions - asthma, diabetes, heart failure, and migraine. The goal of the review was
Autor:
John Doyle, Laura M. Katz, Lisa C. Rosenblatt, Jamie B. Howell, Marya D. Zilberberg, Catherine Tak Piech, Lee Stern
Publikováno v:
American journal of hematology. 81(11)
A retrospective database analysis was conducted to evaluate hospitalization outcomes and charges among elderly acute myeloid leukemia (AML) patients. The data source was a longitudinal (2000-2003) inpatient database from 28 US hospitals. Data on 275
Autor:
Christine Weston, Neil I. Goldfarb, Jamie B Howell, Deborah Moretti, Anthony J. DiMarino, Nicole Cobb, Laura T. Pizzi, Anthony Infantolino, Sidney Cohen
Publikováno v:
Inflammatory bowel diseases. 12(1)
Background: Although studies suggest that inflammatory bowel disease (IBD) has a significant impact on an individual's health-related quality of life, the added weight of other health conditions and comorbidities has not been investigated. The purpos
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 61(1)
Institutional pharmacy practice has undergone dramatic changes over the past few years. Hospitals are moving from using handwritten medication profiles toward implementing computerized ordering and dispensing systems. Efficiencies resulting from thes
Publikováno v:
Blood. 104:5306-5306
Background: Understanding current dosing patterns of epoetin alfa (EPO) and darbepoetin alfa (DARB) in clinical practice and their association with provider visits is important to optimize patient management and assess the total costs of anemia care.
Publikováno v:
Blood. 104:5307-5307
Background: Understanding patients’ preferences regarding treatment features is important, as they may not be aligned with those of providers. Epoetin alfa (EPO) and darbepoetin alfa (DARB) are two erythropoietic agents indicated for the treatment
Publikováno v:
Blood. 104:5313-5313
Background: Comparing dose utilization in actual practice in a defined patient population and setting for both epoetin alfa (EPO) and darbepoetin alfa (DARB) may improve understanding of the dose ratio at which these two agents are equally effective
Autor:
Laura M. Katz, Jamie B. Howell, John J. Doyle, Lee S. Stern, Lisa C. Rosenblatt, Catherine Tak Piech, Marya D. Zilberberg
Publikováno v:
American Journal of Hematology; Nov2006, Vol. 81 Issue 11, p850-857, 8p